Jefferies Financial Group
SLS icon

Jefferies Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Jefferies Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$308K Sell
25,000
-175,459
-88% -$2.2M ﹤0.01% 1069
2026
Q2 		$2.96M Buy
+200,459
New +$1.38M 0.02% 545
2026
Q1 		– Sell
-10,100
Closed -$38.1K – 2167
2025
Q4 		$38.1K Buy
+10,100
New +$19.6K ﹤0.01% 1777

Other funds holding SLS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Jefferies Financial Group's SLS Position: Q3 2026 in Review

Jefferies Financial Group reduced its SELLAS Life Sciences (SLS) stake by 88% in Q3 2026, selling an estimated $2.2M and leaving 25,000 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Jefferies Financial Group first reported a position in SLS in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.96M in Q2 2026. 112 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Jefferies Financial Group held 25,000 shares of SELLAS Life Sciences worth $308K as of Q3 2026.
  • Jefferies Financial Group sold 175,459 SELLAS Life Sciences shares in Q3 2026, an estimated $2.2M.
  • SELLAS Life Sciences made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #1069 holding.
  • Jefferies Financial Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Jefferies Financial Group's SELLAS Life Sciences position peaked at $2.96M in Q2 2026.
  • 112 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.